Sigma Planning »

Cognition Therapeutics shares owned by Sigma Planning

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Sigma Planning from 13F filings

Historical chart of Sigma Planning investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Sigma Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Sigma Planning

Quarter filed Position value Share count Share price at filing
2024-03-31 $290k 159k 1.82
2023-12-31 $53k 29k 1.85

More positions owned by Sigma Planning

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Div Grwth (DGRO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Core S&p Mcp Etf (IJH)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Sigma Planning

Top funds holding Cognition Therapeutics

Pathstone Holdings
AIGH Capital Management
Vanguard Group
Worth Venture Partners
Kestra Advisory Services
American Financial Group
Sigma Planning
Mercer Global Advisors
Commonwealth Equity Services
Texas Capital Bank Wealth Management Services
Fca Corp
Castle Wealth Management
HighTower Advisors
Northeast Financial Consultants
Bangor Savings Bank

View all funds holding Cognition Therapeutics